Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer
Small · 2024
DOI: 10.1002/smll.202309279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Chen Jian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanoparticles, Cancer-Associated Fibroblasts, Cellular Senescence. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Natural Science Foundation, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Radiation resistance in breast cancer resulting in residual lesions or recurrence is a significant cause to radiotherapy failure. Cancer‐associated fibroblasts (CAFs) and radiotherapy‐induced senescent CAFs can further lead to radiation resistance and tumor immunosuppressive microenvironment. Here, an engineering cancer‐cell‐biomimetic nanoplatform is constructed for dual‐targeted clearance of CAFs as well as senescent CAFs. The nanoplatform is prepared by 4T1 cell membrane vesicles chimerized with FAP single‐chain fragment variable as the biomimetic shell for targeting of CAFs and senescent CAFs, and PLGA nanoparticles (NPs) co‐encapsulated with nintedanib and ABT‐263 as the core for clearance of CAFs and senescent CAFs, which are noted as FAP‐CAR‐CM@PLGA‐AB NPs. It is evidenced that FAP‐CAR‐CM@PLGA‐AB NPs directly suppressed the tumor‐promoting effect of senescent CAFs. It also exhibits prolonged blood circulation and enhanced tumor accumulation, dual‐cleared CAFs and senescent CAFs, improved radiation resistance in both acquired and patient‐derived radioresistant tumor cells, and effective antitumor effect with the tumor suppression rate of 86.7%. In addition, FAP‐CAR‐CM@PLGA‐AB NPs reverse the tumor immunosuppressive microenvironment and enhance systemic antitumor immunity. The biomimetic system for dual‐targeted clearance of CAFs and senescent CAFs provides a potential strategy for enhancing the radio‐sensitization of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, 430022, China.
- Key Laboratory for Thin Film and Microfabrication Technology of the Ministry of Education, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Institute of Nano…
ORCID-Profile: Chen Shi
Förderung
- National Natural Science Foundation of China
- Shanghai Natural Science Foundation
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C. (2024). Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer. Small. https://doi.org/10.1002/smll.202309279
Vancouver
Jian C, Wu T, Wang L, Gao C, Fu Z, Zhang Q, et al. Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer. Small. 2024. doi:10.1002/smll.202309279
BibTeX
@article{Jian2024,
author = {Jian, Chen and Wu, Tingting and Wang, Lulu and Gao, Chen and Fu, Zhiwen and Zhang, Qian and Shi, Chen},
title = {Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202309279}
}
EUVIMED